HC Wainwright Lowers MediWound (NASDAQ:MDWD) Price Target to $25.00

MediWound (NASDAQ:MDWD – Free Report) had its target price decreased by HC Wainwright from $28.00 to $25.00 in a report released on Wednesday morning,Benzinga reports. HC Wainwright currently has a buy rating on the biopharmaceutical company’s stock. Separately, StockNews.com raised shares of MediWound to a “sell” rating in a research note on Monday, August 5th. […]

Leave a Reply

Your email address will not be published.

Previous post Citius Oncology (NASDAQ:CTOR) Research Coverage Started at Maxim Group
Next post Today in History: November 30, WTO protesters and police clash in Seattle